06/11/2025
Chronic pain in your dog is triggering SARCOPENIA....a silent, lethal muscle-wasting process that predicts early death even when inflammation is controlled. Your dog with arthritis, hip dysplasia, or joint issues might still be walking. Still wagging. Still eating.
⏰ TIME IS TICKING
Here's what's happening right now inside your dog:
1: Pain blocks full muscle engagement. Dogs with joint pain take cautious steps, avoid stairs, shorten their stride. It looks like movement but deep stabilising muscles stay DORMANT (they are not using it) and begin to ATROPHY (waste away)
2: Unused muscle fibers shrink. Strength drops 15-20%. Simple movements: standing, climbing, turning, become harder.
3: Weak muscles can't support joints. Strain increases. Pain escalates. Your dog moves even less. The death spiral accelerates.
4: Mobility plummets. Energy fades. Welfare and happiness scores drop by up to 350%. Risk of early death skyrockets.
🧠 THE HUMAN TRUTH
In humans, sarcopenia shortens life by 56%. In dogs, the decline is faster, crueler, and often invisible until it's too late. See our article for the recent research on this.
⚠️ THE COST OF INACTION
Every week of pain-driven underuse = irreversible muscle loss
Every month of cautious movement = accelerated aging
Every year of unaddressed sarcopenia = stolen time with your dog
This is not about comfort. This is about survival.
🚨 WHY YOUR DOG IS STILL DECLINING—EVEN ON "THE BEST" TREATMENTS
NSAIDs (pain killers) and joint chews reduce inflammation but cannot rebuild muscles that pain has shut down.
Joint supplements improve cartilage but cannot force disengaged stabilisers to fire again.
Veterinarians, faced with a patient who’s still limping or slowing down, often have no choice but to adjust — higher doses of NSAIDs, add-on painkillers, maybe gabapentin or amantadine. These changes aren’t because the medication “stops working” they’re because the underlying muscle deterioration and pain sensitisation haven’t been addressed. The meds treat the symptoms, not the source of the spiral.
This is why dosage escalation happens, and why the “medication cascade” is so common:
The joint gets weaker as muscle support fades.
Pain persists despite anti-inflammatories.
The nervous system becomes more reactive, needing stronger suppression.
Quality of life gradually slips away under the illusion of treatment.
Breaking that cycle requires addressing the missing piece — the muscle and movement system itself. When you restore circulation, relieve fascial tension, and help dormant muscles fire again, you reprogram the body’s pain response. That’s the real mechanism behind why a targeted muscle therapy, like your Aches & Pains Rub, fits into the science: it bridges the gap between pain control and physical restoration.
So yes — this is exactly why medication doses keep rising, and new drugs keep getting added. Not because the dog is getting worse despite treatment, but because the treatment never targeted the thing pain had already stolen: muscle function.
The Missing Piece: Aches & Pains Rub
A botanical therapy that works where pills and joint chews can't reach:
✓ Loosens fascial restrictions blocking muscle activation
✓ Calms nerve irritation keeping dogs in protective patterns
✓ Supports circulation to wasted tissue
✓ 7 synergistic botanicals to unlock movement and rebuild strength
⏳ EVERY DAY COUNTS. ACT NOW.
👉 [SHOP NOW & SAVE YOUR DOG'S STRENGTH]
20% OFF Aches & Pains Rub (ONE BOTTLE LASTS MONTHS)
FREE Pandora-style silver talisman (worth £15)
30-day money-back guarantee – Try it risk-free
https://myfurbabies.co.uk/collections/home-page-products/products/dog-cat-hip-joint-rub
Sarcopenia doesn't pause. It doesn't reverse on its own. And every day of inaction is muscle, mobility, and precious time lost forever.
Give your dog the chance to move freely, play again, and live the good life they deserve.
📚 References
Hetrick K., Harkin K.R., Roush J.K. Evaluation of Fortetropin in Geriatric and Senior Dogs with Reduced Mobility. PMC, 2022.
Stevens C. et al. Greater hind-limb muscle atrophy is associated with reduced activity in dogs with osteoarthritis. Frontiers in Veterinary Science, 2025.
Adams V.J. et al. Determinants of successful ageing in Labrador retrievers. Acta Vet Scand., 2016.
Millis D.L., Ciuperca I.A. Evidence for canine rehabilitation and physical therapy. Vet Clin Small Anim., 2015.
Cruz-Jentoft A.J. et al. Sarcopenia: European consensus on definition and diagnosis. Age and Ageing, 2010.
